Litigation over Bayer’s weedkillers is just one of the company’s problems. Expiring patents on its top-selling drugs could pose another headache.
BERLIN—Bayer AG, embroiled in a legal battle over whether its weedkillers cause cancer, faces another potentially big problem: expiring patents on its top-selling drugs, with no emerging winners in its pipeline.
The company that invented aspirin is approaching a so-called patent cliff, the point at which a drug’s patent protection runs out and manufacturers of generic drugs can start marketing the compound. That invariably results in a steep drop in sales for the patent owner.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Regulators just approved the first new depression drug since the 1980s, and some see blockbuster potentialA drug inspired by ketamine just became the first new type of depression drug in 35 years. The FDA approved the nasal spray made by Johnson & Johnson.
Read more »
Opinion | The next Chicago mayor will make history — and face a staggering fiscal challengeOpinion: The next Chicago mayor will make history — and face a staggering fiscal challenge
Read more »
“Repurposing” off-patent drugs offers big hopes of new treatmentsEven governments keen to pump cash into drug development prioritise drugs with patents. That needs to change
Read more »
Fund manager with $4,000 Tesla target says this is the next big thing for stockThe ARK Innovation ETF has blazed past the rest of the market this year. Its top holding is about to rip higher, says fund manager Cathie Wood.
Read more »
There's now only one Blockbuster left on the planetCNN News, delivered. Select from our newsletters below and enter your email to subscribe.
Read more »